Instruction for use: CutivateI want this, give me price
Active substance Fluticasone
ATX code D07AC17 Fluticasone
Nosological classification (ICD-10)
L20 Atopic dermatitis
Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis
L20.0 Pochemuha Bienier
L21 Seborrheic dermatitis
Dermatitis seborrheic, Increased sebum separation, Seborrheic Eczema, Seborrheic dermatitis of the scalp, Seborrheic pyodermatitis, Seborrhea, Eczema seborrheic
Itching with partial obstruction of the biliary tract, Dermatitis itchy, Dermatosis with persistent itching, Other itching dermatoses, Itching dermatoses, Itching allergic dermatosis, Itching dermatitis, Itching itch, Excruciating itching, Severe itching, Endogenous itching, Skin itching with dermatosis, Limited itching dermatitis, Itching of the skin, Itchy scalp, Itching eczema
L30.4 Erythematous intertrigo
Erythema of the buttocks, Dermatitis traumatic, Intertrigo, Interdigital intertrigo
Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen
L43 Red Leaf Flat
Lishay Wilson, Erosive-ulcerative form of red flat lichen, Warty forms of red lichen, Red lichen, Flat lichen, Kebner phenomenon
L53 Other erythematous conditions
Variable erythrokeratodermia, Malignant exudative erythema, Erythema, Erythematous, Erythroderma, Erythema from diapers
L93.0 Discoid lupus erythematosus
Chronic discoid lupus erythematosus, Red discoid lupus, Discoid lupus, Discoid erythematosis
T78.4 Allergy, unspecified
Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy
Composition and form of release
Ointment 1 g
Fluticasone propionate 50 μg
Auxiliary substances: propylene glycol; Sorbitan sesquioleate; Microcrystalline wax; Liquid paraffin
In tubes of 15 g; In a pack of cardboard 1 tuba.
Cream 1 g
Fluticasone propionate 500 μg
Auxiliary substances: liquid paraffin; Isopropyl myristate; Cetostearyl alcohol; Ketomacrogol 1000; Propylene glycol; Imidourea; Sodium phosphate; Citric acid monohydrate; purified water
In tubes of 15 g; In a pack of cardboard 1 tuba.
Pharmacological action - anti-inflammatory, antiallergic, antipruritic.
Has glucocorticoid activity.
Eczema (atopic, discoid, in children); Knotty pruritis; Psoriasis (excluding common plaque); Neurodermatosis (including simple lichen, red lichen, seborrheic dermatitis); Discoid lupus erythematosus; Red sweats; Generalized erythroderma (as an additional tool for systemic therapy); Insect bites, allergic contact reactions, itching.
Hypersensitivity, acne pink and ordinary, perioral dermatitis, primary viral, fungal and bacterial skin infections, itching of the anogenital area.
Application in pregnancy and lactation
Perhaps, if the expected effect of therapy exceeds the potential risk to the fetus.
Allergic contact dermatitis, local allergic reactions: burning and itching (require drug discontinuation), secondary infections. With prolonged use in high doses - local atrophic changes in the skin (thinning, striae, widening of the surface vessels, hypertrichosis, hypopigmentation), systemic absorption with signs of hypercorticism, oppression of adrenal cortex function, relapse, tolerance.
Dosing and Administration
Treatment of acute and chronic dermatoses. Ointment or cream is applied a thin layer on the affected skin 1-2 times a day. The course of treatment - 2 weeks.
Reducing the risk of recurrence of the disease. After achieving a therapeutic effect in the acute phase of the disease, the frequency of ointment or cream is reduced: it is recommended to apply the drug once or twice a week without applying an occlusive dressing. Kutiveyt is applied to all previously affected areas of the skin or to areas where a relapse of the disease can be expected.
Avoid contact with eyes (local irritation, increased intraocular pressure). Therapy of secondarily infected lesions requires the use of appropriate antibacterial agents, and the appearance of signs of the spread of infection - the cancellation of Kutiveyt. Before applying a new dressing, the skin should be thoroughly processed.
At a temperature not exceeding 30 ° C.
Keep out of the reach of children.
Do not use after the expiry date printed on the package.